Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 11
Results: 13
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1241, doi. 10.1002/cpdd.833
- Publication type:
- Article
Bioequivalence of Pomalidomide Capsules in Fasting and Fed States in Healthy Male Volunteers: A Randomized, Open, Single‐Dose, Biperiodic, Double‐Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1246, doi. 10.1002/cpdd.1173
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1349, doi. 10.1002/cpdd.1169
- By:
- Publication type:
- Article
Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1284, doi. 10.1002/cpdd.1165
- By:
- Publication type:
- Article
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1294, doi. 10.1002/cpdd.1153
- By:
- Publication type:
- Article
An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1341, doi. 10.1002/cpdd.1150
- By:
- Publication type:
- Article
Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1264, doi. 10.1002/cpdd.1145
- By:
- Publication type:
- Article
An Open‐Label, Randomized Pharmacokinetic Study of 2 Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1322, doi. 10.1002/cpdd.1144
- By:
- Publication type:
- Article
Pharmacokinetics of Amoxicillin and Clavulanate Potassium for Suspension (200 mg/28.5 mg) in Healthy Subjects: Sample Add Stabilizer Study and Food Effects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1314, doi. 10.1002/cpdd.1143
- By:
- Publication type:
- Article
Effect of Meal Timings and Meal Content on the AUC<sub>0‐12h</sub> of Mycophenolic Acid: A Simulation Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1331, doi. 10.1002/cpdd.1141
- By:
- Publication type:
- Article
Drug‐Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1253, doi. 10.1002/cpdd.1140
- By:
- Publication type:
- Article
Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1308, doi. 10.1002/cpdd.1139
- By:
- Publication type:
- Article
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1273, doi. 10.1002/cpdd.1136
- By:
- Publication type:
- Article